Heterozygous mutation (G/G→G/A) at nt 2607 of the EGFR gene is closely associated with increases in EGFR copy number and mRNA half life, but impaired EGFR protein synthesis in squamous cell carcinomas of the head and neck – implication for gefitinib efficacy

Gefitinib (ZD1839, Iressa(®)) is an orally active agent that inhibits the tyrosine kinase activity of epidermal growth factor receptor (EGFR). Gefitinib has shown a high efficacy in patients with non-small cell lung carcinoma and specific mutations in the ATP-binding pocket of EGFR. These mutations,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: NAKAZAKI, KOUICHI, KATO, YASUMASA, TAGUCHI, TAKAHIDE, INAYAMA, YOSHIZAKI, ISHIGURO, YUKARI, KONDO, NORIO, HORIUCHI, CHOUICHI, SAKAKIBARA, ATUKO, TSUKUDA, MAMORU
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2010
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3412478/
https://ncbi.nlm.nih.gov/pubmed/22870104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2010.188
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk